327 related articles for article (PubMed ID: 9259594)
21. cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase.
Moro MA; Russel RJ; Cellek S; Lizasoain I; Su Y; Darley-Usmar VM; Radomski MW; Moncada S
Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1480-5. PubMed ID: 8643658
[TBL] [Abstract][Full Text] [Related]
22. Regulation of vascular smooth muscle soluble guanylate cyclase activity, mRNA, and protein levels by cAMP-elevating agents.
Papapetropoulos A; Marczin N; Mora G; Milici A; Murad F; Catravas JD
Hypertension; 1995 Oct; 26(4):696-704. PubMed ID: 7558233
[TBL] [Abstract][Full Text] [Related]
23. cGMP accumulation and gene expression of soluble guanylate cyclase in human vascular tissue.
Papapetropoulos A; Cziraki A; Rubin JW; Stone CD; Catravas JD
J Cell Physiol; 1996 May; 167(2):213-21. PubMed ID: 8613461
[TBL] [Abstract][Full Text] [Related]
24. Nitric oxide and cyclic GMP increase the expression of matrix metalloproteinase-9 in vascular smooth muscle.
Marcet-Palacios M; Graham K; Cass C; Befus AD; Mayers I; Radomski MW
J Pharmacol Exp Ther; 2003 Oct; 307(1):429-36. PubMed ID: 12954809
[TBL] [Abstract][Full Text] [Related]
25. Role of phosphodiesterase 3 in NO/cGMP-mediated antiinflammatory effects in vascular smooth muscle cells.
Aizawa T; Wei H; Miano JM; Abe J; Berk BC; Yan C
Circ Res; 2003 Sep; 93(5):406-13. PubMed ID: 12919948
[TBL] [Abstract][Full Text] [Related]
26. Soluble guanylyl cyclase expression is reduced in LPS-induced lung injury.
Glynos C; Kotanidou A; Orfanos SE; Zhou Z; Simoes DC; Magkou C; Roussos C; Papapetropoulos A
Am J Physiol Regul Integr Comp Physiol; 2007 Apr; 292(4):R1448-55. PubMed ID: 17204594
[TBL] [Abstract][Full Text] [Related]
27. Novel guanylyl cyclase inhibitor potently inhibits cyclic GMP accumulation in endothelial cells and relaxation of bovine pulmonary artery.
Brunner F; Schmidt K; Nielsen EB; Mayer B
J Pharmacol Exp Ther; 1996 Apr; 277(1):48-53. PubMed ID: 8613957
[TBL] [Abstract][Full Text] [Related]
28. Nitric oxide inhibits whole-cell current in cystic fibrosis pancreatic epithelial cells.
Thethi K; Duszyk M
Pancreas; 1999 Aug; 19(2):158-66. PubMed ID: 10438163
[TBL] [Abstract][Full Text] [Related]
29. Rapid and delayed p42/p44 mitogen-activated protein kinase activation by nitric oxide: the role of cyclic GMP and tyrosine phosphatase inhibition.
Callsen D; Pfeilschifter J; Brüne B
J Immunol; 1998 Nov; 161(9):4852-8. PubMed ID: 9794418
[TBL] [Abstract][Full Text] [Related]
30. Nitric oxide preconditioning regulates endothelial monolayer integrity via the heat shock protein 90-soluble guanylate cyclase pathway.
Antonova GN; Snead CM; Antonov AS; Dimitropoulou C; Venema RC; Catravas JD
Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H893-903. PubMed ID: 17012359
[TBL] [Abstract][Full Text] [Related]
31. Effects of a novel guanylate cyclase inhibitor on nitric oxide-dependent inhibitory neurotransmission in canine proximal colon.
Franck H; Sweeney KM; Sanders KM; Shuttleworth CW
Br J Pharmacol; 1997 Nov; 122(6):1223-9. PubMed ID: 9401790
[TBL] [Abstract][Full Text] [Related]
32. Effects of chronic hypoxia on soluble guanylate cyclase activity in fetal and adult ovine cerebral arteries.
Pearce WJ; Williams JM; White CR; Lincoln TM
J Appl Physiol (1985); 2009 Jul; 107(1):192-9. PubMed ID: 19407253
[TBL] [Abstract][Full Text] [Related]
33. Expression and functional role of the RhoA/Rho-kinase pathway in rat coeliac artery.
Teixeira CE; Jin L; Ying Z; Palmer T; Priviero FB; Webb RC
Clin Exp Pharmacol Physiol; 2005 Oct; 32(10):817-24. PubMed ID: 16173942
[TBL] [Abstract][Full Text] [Related]
34. Desensitization of the soluble guanylyl cyclase/cGMP pathway by lipopolysaccharide in rat isolated pulmonary artery but not aorta.
El-Awady MS; Smirnov SV; Watson ML
Br J Pharmacol; 2008 Dec; 155(8):1164-73. PubMed ID: 18806822
[TBL] [Abstract][Full Text] [Related]
35. Cinaciguat, a soluble guanylate cyclase activator, augments cGMP after oxidative stress and causes pulmonary vasodilation in neonatal pulmonary hypertension.
Chester M; Seedorf G; Tourneux P; Gien J; Tseng N; Grover T; Wright J; Stasch JP; Abman SH
Am J Physiol Lung Cell Mol Physiol; 2011 Nov; 301(5):L755-64. PubMed ID: 21856817
[TBL] [Abstract][Full Text] [Related]
36. Tirofiban increases soluble guanylate cyclase in rat vascular walls: pharmacological and pathophysiological consequences.
Ruiz-Torres MP; Griera M; Chamorro A; Díez-Marqués ML; Rodríguez-Puyol D; Rodríguez-Puyol M
Cardiovasc Res; 2009 Apr; 82(1):125-32. PubMed ID: 19126601
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of rat platelet aggregation by the diazeniumdiolate nitric oxide donor MAHMA NONOate.
Homer KL; Wanstall JC
Br J Pharmacol; 2002 Dec; 137(7):1071-81. PubMed ID: 12429580
[TBL] [Abstract][Full Text] [Related]
38. Nitric oxide induces phosphodiesterase 4B expression in rat pulmonary artery smooth muscle cells.
Busch CJ; Liu H; Graveline AR; Bloch KD
Am J Physiol Lung Cell Mol Physiol; 2006 Apr; 290(4):L747-L753. PubMed ID: 16299053
[TBL] [Abstract][Full Text] [Related]
39. Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase.
Olesen SP; Drejer J; Axelsson O; Moldt P; Bang L; Nielsen-Kudsk JE; Busse R; Mülsch A
Br J Pharmacol; 1998 Jan; 123(2):299-309. PubMed ID: 9489619
[TBL] [Abstract][Full Text] [Related]
40. Adenovirus-mediated gene transfer of cGMP-dependent protein kinase increases the sensitivity of cultured vascular smooth muscle cells to the antiproliferative and pro-apoptotic effects of nitric oxide/cGMP.
Chiche JD; Schlutsmeyer SM; Bloch DB; de la Monte SM; Roberts JD; Filippov G; Janssens SP; Rosenzweig A; Bloch KD
J Biol Chem; 1998 Dec; 273(51):34263-71. PubMed ID: 9852090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
